Metipranolol
Pair of enantiomers
- S01ED04 (WHO) C07BA68 (WHO)
- (RS)-4-{[-2-hydroxy-3-(isopropylamino)propyl]oxy}-2,3,6-trimethylphenyl acetate
- 22664-55-7
- 31477
- 7239
- DB01214 Y
- 29193 Y
- X39AL81KEB
- D02374 Y
- ChEMBL1291 Y
- DTXSID4046078
- Interactive image
- O=C(Oc1c(c(c(OCC(O)CNC(C)C)cc1C)C)C)C
InChI
- InChI=1S/C17H27NO4/c1-10(2)18-8-15(20)9-21-16-7-11(3)17(22-14(6)19)13(5)12(16)4/h7,10,15,18,20H,8-9H2,1-6H3 Y
- Key:BQIPXWYNLPYNHW-UHFFFAOYSA-N Y
Metipranolol (OptiPranolol, Betanol, Disorat, Trimepranol) is a non-selective beta blocker used in eye drops to treat glaucoma. It is rapidly metabolized into desacetylmetipranolol.[1]
References
- ^ Maffei Facino R, Bertuletti R, Carini M, Tofanetti O (1980). "In vitro metabolism of methypranolol by rat liver". Analytical Chemistry Symposia Series. 4 (6): 217–223.
- v
- t
- e
- Apraclonidine
- Brimonidine (+timolol)
- Clonidine
- Dipivefrine
- Epinephrine
muscarinic | |
---|---|
muscarinic/nicotinic | |
acetylcholinesterase inhibitors |
(sulfonamides)
- Befunolol
- Betaxolol
- Carteolol
- Levobunolol
- Metipranolol
- Timolol
- Mepindolol
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e